CBUS · NASDAQ · Biotechnology

Cibus (CBUS)

Develops crop traits through gene editing and licenses them to seed companies.

$1.59
After-hours close−0.02 (−1.12%)
At close$1.61(+3.08%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue011111111121
Cost of revenue202202000011
Gross profit−11−1−120111100
25270172120218431916151313
Research & development181412131312121211999
Selling, general & administrative7758871075554
Other expenses024900181−221000−10
Operating income−26−269−18−21−200−18−42−18−15−13−12−13
−9−8−9−7−1−8−8−9−9−18−9−9
Interest income000000000000
Interest expense8889988999−99
Other non-operating income900−2−80−100900
Income before tax−35−277−27−28−201−26−49−27−24−32−21−22
Income tax expense000000000000
Net income from continuing operations−35−277−27−28−201−26−49−27−24−32−21−22
Other adjustments0700000002000
Net income−26−207−23−25−180−23−47−25−24−31−21−22
EPS, basic−$0.09−$12.02−$1.12−$1.14−$7.63−$0.83−$1.34−$0.61−$0.44−$0.59−$0.33−$0.29
EPS, diluted−$0.09−$12.02−$1.12−$1.14−$7.63−$0.83−$1.34−$0.61−$0.44−$0.59−$0.33−$0.29
Weighted average shares, basic3911721222428354253536577
Weighted average shares, diluted3911721222428354253536577
EBITDA−33−267−17−18−193−16−41−18−15−21−11−12
Depreciation & amortization222202000111
EBIT−35−269−19−20−193−18−41−18−15−23−12−13